The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study of ribociclib (LEE011) plus fulvestrant for the treatment of postmenopausal patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (aBC) who have received no or only one line of prior endocrine treatment (ET): MONALEESA-3.
 
Peter A. Fasching
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Novartis; Pfizer; Roche; Teva
Research Funding - Amgen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Guy Heinrich Maria Jerusalem
Honoraria - Celgene; Novartis; Roche
Consulting or Advisory Role - Amgen; Celgene; Novartis; Pfizer; Roche
Research Funding - MSD; Novartis; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Xavier Pivot
Honoraria - Amgen; Eisai
Consulting or Advisory Role - Novartis; Pierre Fabre; Roche
 
Miguel Martin
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst)
 
Michele De Laurentiis
Consulting or Advisory Role - Amgen; AstraZeneca; Genomic Health; Novartis; Pfizer; Roche
 
Kimberly L. Blackwell
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech; Hospira; Novartis; Pfizer; Roche; Rockwell Medical; Sandoz
Research Funding - Celgene (Inst); Genentech (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Genentech; Hospira; Novartis; Pfizer; Roche; Rockwell Medical; Sandoz
 
Francisco J. Esteva
Leadership - Viatar CTC Solutions, Inc.
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis
Patents, Royalties, Other Intellectual Property - Myriad Genetics (royalties)
Travel, Accommodations, Expenses - Novartis
 
Stephen K. L. Chia
Honoraria - Genomic Health; Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Speakers' Bureau - Genomic Health; Novartis
Research Funding - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Roche
 
Caroline Germa
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Zhongwen Tang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Shyeilla V. Dhuria
Employment - Novartis; Novartis (I)
 
Dennis J. Slamon
No Relationships to Disclose